These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 24145173)

  • 21. Morphoproteomic demonstration of constitutive nuclear factor-kappaB activation in glioblastoma multiforme with genomic correlates and therapeutic implications.
    Brown RE; Law A
    Ann Clin Lab Sci; 2006; 36(4):421-6. PubMed ID: 17127728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MiR-218 reverses high invasiveness of glioblastoma cells by targeting the oncogenic transcription factor LEF1.
    Liu Y; Yan W; Zhang W; Chen L; You G; Bao Z; Wang Y; Wang H; Kang C; Jiang T
    Oncol Rep; 2012 Sep; 28(3):1013-21. PubMed ID: 22766851
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blockade of TGF-β signaling by the TGFβR-I kinase inhibitor LY2109761 enhances radiation response and prolongs survival in glioblastoma.
    Zhang M; Kleber S; Röhrich M; Timke C; Han N; Tuettenberg J; Martin-Villalba A; Debus J; Peschke P; Wirkner U; Lahn M; Huber PE
    Cancer Res; 2011 Dec; 71(23):7155-67. PubMed ID: 22006998
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integrin involvement in glioblastoma multiforme: possible regulation by NF-kappaB.
    Ritchie CK; Giordano A; Khalili K
    J Cell Physiol; 2000 Aug; 184(2):214-21. PubMed ID: 10867646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Livin mediates tumor cell invasion in the DU-145 cell line via NF-κB.
    Chen F; Yang D; Che X; Wang J; Li X; Zhang Z; Chen X; Song X
    Oncol Rep; 2012 Jun; 27(6):2010-6. PubMed ID: 22427141
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Upregulation of tissue inhibitor of metalloproteinases (TIMP)-2 promotes matrix metalloproteinase (MMP)-2 activation and cell invasion in a human glioblastoma cell line.
    Lu KV; Jong KA; Rajasekaran AK; Cloughesy TF; Mischel PS
    Lab Invest; 2004 Jan; 84(1):8-20. PubMed ID: 14631378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of phospholipase D enhances matrix metalloproteinase-2 expression and glioma cell invasion via protein kinase C and protein kinase A/NF-kappaB/Sp1-mediated signaling pathways.
    Park MH; Ahn BH; Hong YK; Min do S
    Carcinogenesis; 2009 Feb; 30(2):356-65. PubMed ID: 19126647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of DNA methylation sensitizes glioblastoma for tumor necrosis factor-related apoptosis-inducing ligand-mediated destruction.
    Eramo A; Pallini R; Lotti F; Sette G; Patti M; Bartucci M; Ricci-Vitiani L; Signore M; Stassi G; Larocca LM; Crinò L; Peschle C; De Maria R
    Cancer Res; 2005 Dec; 65(24):11469-77. PubMed ID: 16357155
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of glioblastoma cell invasion by PKC iota and RhoB.
    Baldwin RM; Parolin DA; Lorimer IA
    Oncogene; 2008 Jun; 27(25):3587-95. PubMed ID: 18212741
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of Ras farnesylation by lovastatin leads to downregulation of proliferation and migration in primary cultured human glioblastoma cells.
    Bouterfa HL; Sattelmeyer V; Czub S; Vordermark D; Roosen K; Tonn JC
    Anticancer Res; 2000; 20(4):2761-71. PubMed ID: 10953355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of invasion and experimental metastasis of murine melanoma cells by Ipomoea obscura (L.) is mediated through the down-regulation of inflammatory mediators and matrix-metalloproteinases.
    Hamsa TP; Kuttan G
    J Exp Ther Oncol; 2011; 9(2):139-51. PubMed ID: 21699021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Constitutive NF-kappaB activity regulates the expression of VEGF and IL-8 and tumor angiogenesis of human glioblastoma.
    Xie TX; Xia Z; Zhang N; Gong W; Huang S
    Oncol Rep; 2010 Mar; 23(3):725-32. PubMed ID: 20127012
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 3-Hydroxy-3',4'-dimethoxyflavone suppresses Bcl-w-induced invasive potentials and stemness in glioblastoma multiforme.
    Bae IH; Lee WS; Yun DH; Han YH; Lee JS
    Biochem Biophys Res Commun; 2014 Jul; 450(1):704-10. PubMed ID: 24946210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amentoflavone Effectively Blocked the Tumor Progression of Glioblastoma via Suppression of ERK/NF-
    Hsu FT; Chiang IT; Kuo YC; Hsia TC; Lin CC; Liu YC; Chung JG
    Am J Chin Med; 2019; 47(4):913-931. PubMed ID: 31096773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microenvironment-Derived Regulation of HIF Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme.
    Heiland DH; Gaebelein A; Börries M; Wörner J; Pompe N; Franco P; Heynckes S; Bartholomae M; hAilín DÓ; Carro MS; Prinz M; Weber S; Mader I; Delev D; Schnell O
    Mol Cancer Res; 2018 Apr; 16(4):655-668. PubMed ID: 29330292
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The NFκB pathway: a therapeutic target in glioblastoma.
    Nogueira L; Ruiz-Ontañon P; Vazquez-Barquero A; Moris F; Fernandez-Luna JL
    Oncotarget; 2011 Aug; 2(8):646-53. PubMed ID: 21896960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Secretome signature of invasive glioblastoma multiforme.
    Formolo CA; Williams R; Gordish-Dressman H; MacDonald TJ; Lee NH; Hathout Y
    J Proteome Res; 2011 Jul; 10(7):3149-59. PubMed ID: 21574646
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hematopoietic stem cells as a tool for the treatment of glioblastoma multiforme.
    Bryukhovetskiy IS; Dyuizen IV; Shevchenko VE; Bryukhovetskiy AS; Mischenko PV; Milkina EV; Khotimchenko YS
    Mol Med Rep; 2016 Nov; 14(5):4511-4520. PubMed ID: 27748891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TRAF3IP2, a novel therapeutic target in glioblastoma multiforme.
    Alt EU; Barabadi Z; Pfnür A; Ochoa JE; Daneshimehr F; Lang LM; Lin D; Braun SE; Chandrasekar B; Izadpanah R
    Oncotarget; 2018 Jul; 9(51):29772-29788. PubMed ID: 30038719
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Migration Phenotype of Brain-Cancer Cells Predicts Patient Outcomes.
    Smith CL; Kilic O; Schiapparelli P; Guerrero-Cazares H; Kim DH; Sedora-Roman NI; Gupta S; O'Donnell T; Chaichana KL; Rodriguez FJ; Abbadi S; Park J; Quiñones-Hinojosa A; Levchenko A
    Cell Rep; 2016 Jun; 15(12):2616-24. PubMed ID: 27292647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.